Functional Activities Questionnaire Items that Best Discriminate and Predict Progression from Clinically Normal to Mild Cognitive Impairment
Gad A. Marshall, Dorene M. Rentz(Harvard University), Rebecca E. Amariglio(Harvard University), Natacha Lorius(Brigham and Women's Hospital), Keith A. Johnson(Jacobson Holman (United States)), Reisa A. Sperling(Brigham and Women's Hospital), Joseph J. Locascio(Jacobson Holman (United States)), Amy Zoller(Harvard University)
Cited by 97
Related Papers
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
|Alzheimer s & Dementia|2018|10.4k
Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
|Alzheimer s & Dementia|2011|7.1k
Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease
|New England Journal of Medicine|2012|3.8k
A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's disease
|Alzheimer s & Dementia|2014|3.1k